Suppr超能文献

对三甲基胺 N-氧化物和葡萄糖诱导的大鼠心肌细胞应激的心脏保护作用。

Cardioprotective Role of against Trimethylamine-N-Oxide and Glucose Induced Stress in Rat Cardiomyocytes.

机构信息

Center for Emerging Diseases, Department of Biotechnology, Jaypee Institute of Information Technology, A-10, Sector- 62, Noida, 201307, Uttar Pradesh, India.

出版信息

Cardiovasc Hematol Agents Med Chem. 2024;22(4):475-494. doi: 10.2174/0118715257270512231013064533.

Abstract

BACKGROUND

Type 2 diabetes has become a concern issue that affects the quality of life and can increase the risk of cardiac insufficiency elevating the threat to the life safety of patients. A recognized cause of cardiac insufficiency is diabetic cardiomyopathy, chronic hyperglycemia, and myocardial lipotoxicity which can reduce the myocardial contractile performance, and enhance the cardiomyocyte hypertrophy and interstitial fibrosis. The cause of diabetic cardiomyopathy is multi-factorial which includes oxidative stress, insulin resistance, inflammation, apoptosis, and autophagy. Recent clinical studies have suggested the dysbiosis of gut microbiota, secretion of metabolites, and their diffusion in to the host as to have direct detrimental effects on the cardiac contractility.

MATERIALS AND METHODS

In the present paper, we have done in silico studies including molecular interaction of phytoconstituents of against reactive oxygen species producing proteins. Whereas, in vitro studies were conducted on H9C2 cardiac cells including cell morphological examination, level of reactive oxygen species, cell count-viability, apoptotic status, in the presence of high glucose, trimethylamine-n-oxide, and plant extracts which were determined through cell analyzer and microscopic assays.

RESULTS

The treatment of high glucose and trimethylamine-n-oxide was found to be increase the cardiac stress approximately two fold by attenuating hypertrophic conditions, oxidative stress, and apoptosis in rat cardiomyocytes, and was found to be a cardioprotective agent.

CONCLUSION

Conclusively, our study has reported that the Indian medicinal plant has the ability to treat diabetic cardiomyopathy. Our study can open up a new herbal therapeutic strategy against diabetic cardiomyopathy.

摘要

背景

2 型糖尿病已成为一个令人关注的问题,影响生活质量,并可能增加心脏功能不全的风险,从而威胁到患者的生命安全。已知的心脏功能不全的一个原因是糖尿病心肌病,慢性高血糖和心肌脂肪毒性会降低心肌收缩性能,并增强心肌细胞肥大和间质纤维化。糖尿病心肌病的病因是多因素的,包括氧化应激、胰岛素抵抗、炎症、细胞凋亡和自噬。最近的临床研究表明,肠道微生物群落的失调、代谢物的分泌及其在宿主中的扩散,直接对心肌收缩力产生有害影响。

材料和方法

在本文中,我们进行了计算生物学研究,包括植物成分与产生活性氧的蛋白质的分子相互作用。而在体外研究中,我们使用 H9C2 心脏细胞进行了实验,包括细胞形态学检查、活性氧水平、细胞计数-活力、凋亡状态,在高葡萄糖、三甲胺 N-氧化物和植物提取物存在下,通过细胞分析仪和显微镜检测进行了研究。

结果

高葡萄糖和三甲胺 N-氧化物的处理被发现可通过减轻大鼠心肌细胞的肥大状态、氧化应激和细胞凋亡,将心脏应激增加约两倍,而 被发现是一种心脏保护剂。

结论

总之,我们的研究报告了印度药用植物 具有治疗糖尿病心肌病的能力。我们的研究可以为糖尿病心肌病的治疗开辟新的草药治疗策略。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验